文献速递神经技术与安全MR

钆基对比剂给药后大鼠脑不溶性组分中钆的形态分析

Speciation Analysis of Gadolinium in the Water-Insoluble Rat Brain Fraction After Administration of Gadolinium-Based Contrast Agents.
PubMed 文献 · Invest Radiol · 2021-01-01

研究采用水和尿素序贯提取大鼠脑组织,使组织溶解度达97%±1%,结合SEC-ICP-MS分析钆形态。大环钆特酸葡胺给药1周后脑内钆完全以完整螯合物形式存在;线性钆贝葡胺和钆双胺则发生配体交换,形成与铁蛋白等内源性配体结合的多种钆物种,且不溶性组分中虽仅占脑组织3%却含超过50%的未鉴定钆。

要点

  • 大环GBCA脑内以完整分子形式滞留,线性GBCA则发生配体交换形成多种钆复合物
  • 铁蛋白是脑内与Gd3+反应的大分子之一,提示线性GBCA的脱螯合风险
  • 线性GBCA给药后仅3%不溶性脑组织含超过50%的未鉴定形式钆

核心结论

  • 水和尿素序贯提取可实现大鼠脑组织准完全溶解并显著提高钆回收率,大环钆特酸葡胺在脑内保持完整,线性GBCA发生配体交换形成多种钆复合物。

研究设计与样本

  • 动物实验研究,健康雌性Sprague Dawley大鼠随机分为钆特酸葡胺、钆贝葡胺、钆双胺(累积剂量12 mmol/kg,5次静脉注射)及对照组,末次注射后1周处死。
  • 脑组织经水与尿素序贯提取,采用ICP-MS测定总钆及提取效率,SEC-ICP-MS分析可溶组分中钆形态,以分子大小和保留时间匹配钆螯合物及铁蛋白标准品鉴定物种。
  • 分析脑皮质和小脑两个脑区,通过加标未处理动物脑样本监测GBCA在提取条件下的稳定性,并精确测定柱回收率以区分弱结合与强结合钆复合物。

关键影像表现/征象

  • 钆特酸葡胺组皮质和小脑提取效率分别为97%±1%和102%±3%,SEC-ICP-MS显示所有组分中低nmol/g水平的钆仅以完整GBCA形式存在。
  • 线性GBCA(钆贝葡胺和钆双胺)尿素可溶组分中检测到3种不同流体力学体积的钆物种:大于660 kDa、约440 kDa及完整GBCA。
  • 约440 kDa物种的洗脱体积与Gd3+-铁蛋白复合物一致,且SEC-ICP-MS证实Gd3+在100 mM乙酸铵(pH 7.4)中可与铁蛋白标准品反应。
  • 线性GBCA组柱回收率明显不完全,提示存在游离、水解或与内源性配体弱结合的Gd3+;钆贝葡胺皮质和小脑提取效率分别为49%±1%和46%±4%,钆双胺分别为48%±2%和34%±1%。

临床应用与阅片要点

  • 阅片时无需直接测量钆形态,但应了解大环GBCA脑内滞留为完整分子,线性GBCA可脱螯合并与铁蛋白等内源性配体结合。
  • 线性GBCA的不溶性脑组分虽仅占组织3%,却含超过50%的未鉴定形式钆,提示既往水提取法可能严重低估脑内钆沉积。
  • 关注线性GBCA使用后脑内钆沉积的潜在风险,尤其适用于需多次增强扫描的患者对比剂选择。

局限性

  • 研究为大鼠动物实验,结果不能直接外推至人体。
  • 单中心、样本量有限,仅分析皮质和小脑两个脑区。
  • 线性GBCA组不溶性组分中超过50%的钆未能鉴定其具体形态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To date, the analysis of gadolinium (Gd) speciation in the brain of animals administered with macrocyclic and linear Gd-based contrast agents (GBCAs) has been limited to Gd soluble in mild buffers. Under such conditions, less than 30% of the brain tissue was solubilized and the extraction recoveries of GBCAs into the aqueous phase were poor, especially in the case of the linear GBCAs. The aim of this study was to find the conditions to solubilize the brain tissue (quasi-)completely while preserving the Gd species present. The subsequent analysis using size exclusion chromatography-inductively coupled plasma-mass spectrometry (SEC-ICP-MS) was intended to shed the light on the speciation of the additionally recovered Gd.

METHODS: Four groups of healthy female Sprague Dawley rats (SPF/OFA rats; Charles River, L'Arbresle, France) received randomly 5 intravenous injections (1 injection per week during 5 consecutive weeks) of either gadoterate meglumine, gadobenate dimeglumine, gadodiamide (cumulated dose of 12 mmol/kg), or no injection (control group). The animals were sacrifice 1 week (W1) after the last injection. Brain tissues were solubilized with urea solution, whereas tissues extracted with water served as controls. Total Gd concentrations were determined in the original brain tissue and its soluble and insoluble fractions by inductively coupled plasma-mass spectrometry (ICP-MS) to calculate the Gd accumulation and extraction efficiency. Size exclusion chromatography coupled to ICP-MS was used to monitor the speciation of Gd in the soluble fractions. The stability of GBCAs in the optimum conditions was monitored by spiking the brain samples from the untreated animals. The column recoveries were precisely determined in the purpose of the discrimination of weakly and strongly bound Gd complexes. The identity of the eluted species was explored by the evaluation of the molecular size and retention time matching with Gd chelates and ferritin standard. The speciation analyses were carried out for 2 different brain structures, cortex and cerebellum.

RESULTS: The combination of water and urea extractions (sequential extraction) managed to solubilize efficiently the brain tissue (97% ± 1%) while preserving the stability of the initially injected form of GBCA. For macrocyclic gadoterate, 97% ± 1% and 102% ± 3% of Gd initially present in the cortex and cerebellum were extracted to the soluble fraction. For gadobenate, similar amounts of Gd (49% ± 1% and 46% ± 4%) were recovered from cortex and cerebellum. For gadodiamide, 48% ± 2% of Gd was extracted from cortex and 34% ± 1% from cerebellum. These extraction efficiencies were higher than reported elsewhere. The SEC-ICP-MS and the column recovery determination proved that Gd present at low nmol/g levels in brain tissue was exclusively in the intact GBCA form in all the fractions of brain from the animals treated with gadoterate. For the linear GBCAs (gadobenate and gadodiamide), 3 Gd species of different hydrodynamic volumes were detected in the urea-soluble fraction: (1) larger than 660 kDa, (2) approximately 440 kDa, and (3) intact GBCAs. The species of 440 kDa corresponded, on the basis of the elution volume, to a Gd3+ complex with ferritin. Gd3+ was also demonstrated by SEC-ICP-MS to react with the ferritin standard in 100 mM ammonium acetate (pH 7.4). In contrast to macrocyclic gadoterate, for linear GBCAs, the column recovery was largely incomplete, suggesting the presence of free, hydrolyzed, or weakly bound Gd3+ with endogenous ligands.

CONCLUSIONS: The sequential extraction of rat brain tissue with water and urea solution resulted in quasi-complete solubilization of the tissue and a considerable increase in the recoveries of Gd species in comparison with previous reports. The macrocyclic gadoterate was demonstrated to remain intact in the brain 1 week after administration to rats. The linear GBCAs gadobenate and gadodiamide underwent ligand exchange reactions resulting in the presence of a series of Gd3+ complexes of different strength with endogenous ligands. Ferritin was identified as one of the macromolecules reacting with Gd3+. For the linear GBCAs, 3% of the insoluble brain tissue was found to contain more than 50% of Gd in unidentified form(s).

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Strzeminska I, Factor C, Robert P, et al. Speciation Analysis of Gadolinium in the Water-Insoluble Rat Brain Fraction After Administration of Gadolinium-Based Contrast Agents. Invest Radiol. 2021. PMID: 33813574. doi:10.1097/RLI.0000000000000774

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。